Epidarex secures £50m from British Business Bank for new fund

a bottle of pills spilled onto a blue background al logo on the right, with the Epidarex logo on the right

Epidarex Capital focuses on early-stage life sciences spinouts from medical research institutions in the US and the UK.

This is not a paywall.

Create a free account to read this news story now.

Already a member? Log in here
a headshot of the author

Explore these topics

Region(s): , , , ,
The Next Leap